The head of the U.S. Centers for Disease Control and Prevention said on Feb. 26 that a recent decline in COVID-19 cases may be stalling, a development she described as concerning while urging that safeguards to fight the virus remain in place.
A study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.
Mayor Bill de Blasio’s chief medical adviser on Feb. 25 downplayed the results of two studies suggesting that a new coronavirus variant found in New York City in November will be more resistant to vaccines now being administered.
A new coronavirus variant that shares some similarities with a more transmissible and intractable variant discovered in South Africa is on the rise in New York City, researchers said on Feb. 24.
The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing Covid-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies.
The United States expects to roll out 3 to 4 million doses of Johnson & Johnson’s Covid-19 vaccine during the first week of March, pending authorization from the Food and Drug Administration, White House Covid-19 response coordinator Jeff Zients said on Feb. 24.
Bristol Myers Squibb announced plans for a new manufacturing plant in Devens, Mass., adding to the company’s cell therapy network.
Johnson & Johnson’s one-dose Covid-19 vaccine appeared safe and effective in trials, the U.S. Food and Drug Administration said, paving the way for approval for emergency use as soon as Feb. 26.
Covid-19 vaccine makers told Congress on Feb. 23 that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations.
ReutersJohnson & Johnson expects to be able to ship nearly 4 million doses of the company’s Covid-19 vaccine upon authorization in the U.S., an executive said at a hearing in the U.S. House of Representatives on Feb. 23.